Re: The epidemiology and outcomes of women with postpartum haemorrhage requiring massive transfusion with eight or more units of red cells: a national cross-sectional study Reply by Knight, Marian et al.
documented in 46% of cases reported
in Green et al.’s study.1 The results of
the WOMAN trial3 will provide evi-
dence for wider use of tranexamic
acid specifically in PPH.
Future work on PPH should include
consideration of these important factors
as well as on development of simple
tools which can be easily taught to non-
medical personnel in low resource set-
tings, such as the PPHButterfly device.4n
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Authors’ reply
Sir
We thank Dr Killicoat and colleagues
for their interest in our paper. We agree
that it is important that both trainee
and consultant obstetricians and mid-
wives are skilled in recognising and
managing obstetric haemorrhage.
Haemorrhage remains the second most
frequent cause of direct maternal death
in the UK; there has been no significant
decrease in maternal death rate from
haemorrhage since 2009.1 The most
recent UK Confidential Enquiries into
Maternal Deaths which reviewed the
care of women who died from haemor-
rhage reported that improvements in
care may have made a difference to
outcome in all of the women who died.
The report highlighted a number of key
messages to improve future care of
women with haemorrhage.2
Three women who died were anaemic
in the antenatal period and only one
received oral iron. Haemoglobin levels
below the normal range for pregnancy
should be investigated and iron supple-
mentation considered if indicated to
optimise haemoglobin before delivery.
Inadequate observations were a fea-
ture in seven deaths and abnormal
observations were not escalated in five
women. Physiological observations
including the respiratory rate should
be used to monitor all antenatal and
postnatal admissions. However, it is the
response to the abnormal score that will
affect outcome, not simply its docu-
mentation. Concerns should be esca-
lated to a senior doctor or midwife if a
woman deteriorates, and there should
be a named senior doctor in charge of
ongoing care.
In several deaths an acute point of
care of single haemoglobin measure-
ment result falsely reassured staff. Fluid
resuscitation and blood transfusion
management, which has been described
elsewhere,3 are also important, and
should not be delayed because of false
reassurance from a single haemoglobin
result; the whole clinical picture should
be considered.
In several instances, women deterio-
rated despite ongoing resuscitation
because the source of bleeding was not
stopped. Of particular relevance to the
observations of Dr Killicoat and col-
leagues, eight women had attempted
balloon tamponade and the report notes
that there appeared to be a tendency to
try an intrauterine balloon even when
the situation was extreme. The figures
from Dr Killicoat and colleagues noting
a higher rate of intrauterine balloon use
in women with a haemorrhage of
3000 ml or more perhaps reflects this.
The report highlighted once again the
importance of early recourse to hys-
terectomy if simpler medical and surgi-
cal interventions prove ineffective, and
this applies equally to intrauterine bal-
loon use.n
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Re: Parental physical and lifestyle
factors and their association with
newborn body composition
Sir,
I was interested to read the paper by
McCarthy et al.1 The authors aimed to
evaluate the impact of parental physical
characteristics and lifestyle on newborn
body composition. They found that
adjusted mean difference in neonatal
body fat percentage (BF%) between
maternal smokers and non-smokers
was 0.55 (95% CI 1.07 to 0.03).1
Although the analyses are correct
and the data are interesting, the read-
ers must distinguish difference
between statistical significance and
clinical importance. As a rule of
thumb, clinical importance is more
important than statistical significance
because statistical significance does not
provide information about the effect
size or the clinical relevance.2 Here,
clinically, differences of 0.55 and
0.03 in BF% are nothing and may
even be negligible although they were
statistically significant.
Largesamplesize, largemeandifference
and lower standard deviation of the vari-
able in the study population would easily
change P-value from non-significant to
significant.2 As the authors point out in
their conclusion, there is an association
betweenmaternal smoking and alteredBF
%. It is important to consider the clinical
judgement in this conclusion.n
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Authors’ reply
Sir,
We thank Mr Ayubi for his comments.
We agree, the differentiation between
statistical and clinical significance is
critical to the interpretation of any
new research and we would encourage
readers to do this.
Can we with certainty say that statis-
tically significant differences of small
magnitude amount to nothing and may
be even negligible as Mr Ayubi suggests?
Similarly, although large effects are more
likely to be clinically significant than
small ones, even large effects can be
clinically insignificant. On the other
hand, if the difference between treatment
groups is statistically non-significant, it
may still be clinically important. These
questions are interesting but are well
beyond the scope of this paper, although
they are discussed elsewhere.1–3
We agree the magnitude of some of
these statistically significant effects that
we report is small, but others, such as
maternal waist:height ratio, are of
greater magnitude (adjusted mean dif-
ference 6.59; 95% CI 0.27–12.92) and
likely to be clinically significant.4
Although many of the changes that we
report are of small magnitude, we
believe the combination of all these
measurements supports a trend that
differences in maternal anthropometry
influences neonatal body fat percentage.
How this may translate into clinically
relevant and translational findings is an
ongoing body of work but presenting
these findings in an open and transpar-
ent manner as we have done we feel
allows the reader reach their own
conclusion.n
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Re: Time to optimise and enforce
training in interpretation of
intrapartum cardiotocograph
Time is not ripe for imposing pass/fail
licensing examination in
cardiotocography interpretation in UK
Sir,
The commentary by Ugwumadu et al.1
begins with a demand for
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